Novartis Buys New Cancer Drug for $900 Million

Novartis makes a big move in fighting cancer. The company just spent a lot of money on a new medicine. This drug uses radiation to attack cancer cells. It is called a radioligand therapy. Novartis paid up to $900 million for this new treatment.

This new drug is still in early tests. It comes from a Chinese company that focuses on these kinds of medicines. Novartis wants to grow its lead in this important cancer treatment area. Other companies are also working on similar drugs.

This deal helps Novartis stay ahead. It means more options could be coming for patients battling cancer. These new drugs are precise. They target bad cells while leaving healthy cells alone.

Keep an eye on these developments. New cancer treatments offer hope for many people around the world.

Source: FierceBiotech